|
BCCA Statement on COVID-19 Vaccination in Children
The
Joint Committee on Vaccination and Immunisation (JCVI) has issued new
paediatric guidance on COVID-19 vaccination. The full guidance can be found at: https://www.gov.uk/government/news/jcvi-issues-advice-on-covid-19-vaccination-of-children-and-young-people The JCVI is advising that children at increased risk
of serious COVID-19 disease are offered the Pfizer-BioNTech vaccine. That includes children aged 12 to 15 with severe
neurodisabilities, Down’s syndrome, immunosuppression and multiple or severe
learning disabilities. The JCVI also recommends that children and young
people aged 12 to 17 who live with an immunosuppressed person should be offered
the vaccine.
Currently, the JCVI is not recommending vaccination of children
with congenital heart disease aged 15 years or younger in the absence of the
additional risk factors outlined above. These recommendations will remain under
review as more data becomes available. DOWNLOAD STATEMENT AS A PDF FILE
20 July 2021
Number of views: 5385
|
.gif){kind=small}
.gif){kind=small}
